SCHEMBL30360217

SCHEMBL30360217

CCOC(=O)[C@H](C)CCN.[Na]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 2/20 0.52
CPB2 Q96IY4 2/20 0.44
CYP1A2 P05177 1/20 0.42
ALOX15 P16050 1/20 0.41
ALDH1A1 P00352 3/20 0.39
CYP2C19 P33261 2/20 0.38
CYP3A4 P08684 1/20 0.38
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GAA P10253 2/20 0.37
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
SOAT1 P35610 1/20 0.36
GABBR2 O75899 2/20 0.35
GABBR1 Q9UBS5 2/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4639637 0.98 GABRR1 (0.54) GABRR1CPB2CYP1A2ALOX15ALDH1A1
SCHEMBL7879761 0.98 GABRR1 (0.54) GABRR1CPB2CYP1A2ALOX15ALDH1A1
SCHEMBL28212355 0.96 GABRR1 (0.52) GABRR1CPB2CYP1A2ALOX15ALDH1A1
SCHEMBL28212354 0.96 GABRR1 (0.52) GABRR1CPB2CYP1A2ALOX15ALDH1A1
SCHEMBL9411898 0.85 CPB2 (0.51) GABRR1CPB2CYP1A2ALOX15ALDH1A1
SCHEMBL14616914 0.84 ALDH1A1 (0.48) GABRR1CPB2CYP1A2ALOX15ALDH1A1
SCHEMBL518315 0.83 CPB2 (0.59) GABRR1CPB2CYP1A2ALOX15ALDH1A1
Hydrochloric Acid SCHEMBL28252625 0.83 CPB2 (0.50) GABRR1CPB2CYP1A2ALOX15ALDH1A1
SCHEMBL16125818 0.83 CPB2 (0.59) GABRR1CPB2CYP1A2ALOX15ALDH1A1
SCHEMBL9343926 0.82 ALDH1A1 (0.42) GABRR1CPB2CYP1A2ALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11629120-B2 Trisodium sacubitril valsartan and process for its preparation BIOCON LIMITED (IN) 2023-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11629120-B2 Trisodium sacubitril valsartan and process for its preparation AGT, ACE, REN GABRR1 264/4885CPB2 1799/4885CYP1A2 1422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.